Science Explorer Back to mapMap
Discussion
Company · Cambridge · United States

Acceleron Pharma (United States)

acceleronpharma.comROR OpenAlex
World rank, all time
#21,639
of 34,923
Rank in United States
#4,484
of 7,310
Research works
192
▲ 5% vs 2018-21
Citations
6.1k
32.0 per fractional work
Top-10% rate
13.9%
all institutions 10.0%
vs its own fields
1.03×
1.00× is exactly expected
Open access
30%
world 40%
International
19%
world 18%
Acceleron Pharma (United States)

Which fields of science does Acceleron Pharma (United States) work in?

In 2022-now, 54% of research at Acceleron Pharma (United States) is in Physical Sciences, 36% in Health Sciences. Its largest fields are Medicine (36%), Engineering (32%), Physics and Astronomy (18%). It does 1.4× the world's share of Health Sciences.

Physical Sciences: 19 fractional works · 53.7% of its workEngineering: 11 fractional works · 32.5% of its workAerospace Engineering: 11 fractional works · 30.2% of its workElectrical and Electronic Engineering: 0 fractional works · 0.9% of its workMechanical Engineering: 0 fractional works · 0.9% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workPhysics and Astronomy: 6 fractional works · 17.9% of its workAstronomy and Astrophysics: 6 fractional works · 17.9% of its workEnvironmental Science: 1 fractional works · 2.4% of its workEnvironmental Chemistry: 1 fractional works · 2.4% of its workMathematics: 0 fractional works · 0.9% of its workApplied Mathematics: 0 fractional works · 0.9% of its workHealth Sciences: 13 fractional works · 36.1% of its workMedicine: 13 fractional works · 36.1% of its workPulmonary and Respiratory Medicine: 3 fractional works · 10.0% of its workCardiology and Cardiovascular Medicine: 3 fractional works · 7.9% of its workInfectious Diseases: 1 fractional works · 2.6% of its workGenetics: 1 fractional works · 2.4% of its workOphthalmology: 1 fractional works · 2.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.4% of its workNeurology: 0 fractional works · 1.2% of its workEpidemiology: 0 fractional works · 1.1% of its workPhysiology: 0 fractional works · 1.0% of its workHepatology: 0 fractional works · 0.9% of its workRheumatology: 0 fractional works · 0.9% of its workHematology: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.5% of its workReproductive Medicine: 0 fractional works · 0.5% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.0% of its workLife Sciences: 3 fractional works · 8.7% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 5.0% of its workMolecular Biology: 1 fractional works · 2.5% of its workGenetics: 1 fractional works · 2.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 2.1% of its workAnimal Science and Zoology: 1 fractional works · 2.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workPharmaceutical Science: 0 fractional works · 0.9% of its workImmunology and Microbiology: 0 fractional works · 0.5% of its workImmunology: 0 fractional works · 0.5% of its workNeuroscience: 0 fractional works · 0.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 1.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.2% of its workEconomics and Econometrics: 0 fractional works · 1.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.2% of its workManagement Information Systems: 0 fractional works · 0.2% of its workALL ITS WORKAcceleron Pharma(United States)35fractional works, 2022-now
Life Sciences9%Physical Sciences54%Health Sciences36%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Engineering1132.5%
    2. Physics and Astronomy617.9%
    3. Environmental Science12.4%
    4. Mathematics00.9%
    1. Medicine1336.1%
    2. Veterinary00.0%
    1. Biochemistry, Genetics and Molecular Biology25.0%
    2. Agricultural and Biological Sciences12.1%
    3. Pharmacology, Toxicology and Pharmaceutics00.9%
    4. Immunology and Microbiology00.5%
    5. Neuroscience00.2%
    1. Economics, Econometrics and Finance01.2%
    2. Business, Management and Accounting00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.44× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.94× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.45× its world share, 0 worksImmunology and Micro…Neuroscience: 0.15× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.70× its world share, 0 worksPharmacology, Toxico…Engineering: 2.16× its world share, 11 worksEngineeringEnvironmental Science: 0.48× its world share, 1 worksEnvironmental ScienceMathematics: 0.81× its world share, 0 worksMathematicsPhysics and Astronomy: 8.07× its world share, 6 worksPhysics and AstronomyMedicine: 1.88× its world share, 13 worksMedicineVeterinary: 0.24× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.07× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.56× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Physics and Astronomy, 8.1×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Physics and Astronomy8.07×6 works
  2. Pharmacology, Toxicology and Pharmaceutics2.70×0 works
  3. Engineering2.16×11 works
  4. Medicine1.88×13 works
  5. Biochemistry, Genetics and Molecular Biology0.94×2 works
  6. Mathematics0.81×0 works
  7. Economics, Econometrics and Finance0.56×0 works
  8. Environmental Science0.48×1 works
  9. Immunology and Microbiology0.45×0 works
  10. Agricultural and Biological Sciences0.44×1 works
  11. Veterinary0.24×0 works
  12. Neuroscience0.15×0 works
  13. Business, Management and Accounting0.07×0 works

Who are the top researchers at Acceleron Pharma (United States)?

Ranked on the quality score, Jasbir S. Seehra, Monique V. Davies and Dianne Sako lead among researchers whose main affiliation is Acceleron Pharma (United States).

  1. 1 Jasbir S. Seehra United States · #128,063 worldwide 8.5k citations · 112 works
  2. 2 Monique V. Davies United States · #138,888 worldwide 6.6k citations · 42 works
  3. 3 Dianne Sako United States · #244,616 worldwide 4.1k citations · 41 works
  4. 4 Kenneth M. Attie United States · #283,565 worldwide 5.3k citations · 117 works
  5. 5 Travis E. Monnell United States · #475,381 worldwide 1k citations · 37 works
  6. 6 Abderrahmane Laadem United States · #500,542 worldwide 2.5k citations · 106 works
  7. 7 Robert Scott Pearsall United States · #579,311 worldwide 3.2k citations · 106 works
  8. 8 Aaron W. Mulivor United States · #602,553 worldwide 1.8k citations · 44 works
  9. 9 Asya V. Grinberg United States · #705,008 worldwide 2.7k citations · 56 works
  10. 10 Mark J. Alexander United States · #753,396 worldwide 1.4k citations · 19 works
All ranked researchers at Acceleron Pharma (United States)

What are the most cited papers from Acceleron Pharma (United States)?

The most cited paper from Acceleron Pharma (United States) is "Ballistocardiography and Seismocardiography: A Review of Recent Advances" (Omer T. Inan, Pierre‐François Migeotte, Kwangsuk Park et al., 2014), with 772 citations. Next come "DNA-encoded chemistry: enabling the deeper sampling of chemical space" (631) and "Sotatercept for the Treatment of Pulmonary Arterial Hypertension" (616).

Most cited papers
#PaperReleasedCitations
1 Ballistocardiography and Seismocardiography: A Review of Recent Advances Omer T. Inan, Pierre‐François Migeotte, Kwangsuk Park et al. · IEEE Journal of Biomedical and Health Informatics Open access 7 Oct 2014 772
2 DNA-encoded chemistry: enabling the deeper sampling of chemical space Robert A. Goodnow, Christoph E. Dumelin, Anthony D. Keefe · Nature Reviews Drug Discovery Review 9 Dec 2016 631
3 Sotatercept for the Treatment of Pulmonary Arterial Hypertension Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs et al. · New England Journal of Medicine Open access 31 Mar 2021 616
4 Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Pierre Fenaux et al. · New England Journal of Medicine Open access 8 Jan 2020 554
5 Leptin targets in the mouse brain Michael M. Scott, Jennifer L. Lachey, Scott M. Sternson et al. · The Journal of Comparative Neurology Open access 23 Feb 2009 490
All 60 most cited papers, with filters and sorting

Which keywords describe research at Acceleron Pharma (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Echocardiography, CubeSat, small satellite, Space Policy, Space Tourism, Pulmonary Hypertension, Chronic Kidney Disease and Endothelial Dysfunction.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Echocardiography4▲ 38×2 topics
  2. CubeSat3▲ 517×1 topic
  3. small satellite3▲ 517×1 topic
  4. Space Policy3▲ 569×1 topic
  5. Space Tourism3▲ 569×1 topic
  6. Pulmonary Hypertension3▲ 56×2 topics
  7. Chronic Kidney Disease3▲ 29×2 topics
  8. Endothelial Dysfunction3▲ 32×2 topics
  9. Right Heart Assessment3▲ 185×1 topic
  10. Treatment Guidelines3▲ 34×1 topic
  11. Epidemiology2▲ 1.43×11 topics
  12. Biomechanics2▲ 17×2 topics
  13. Extravehicular Activity2▲ 633×1 topic
  14. Immune Response2▲ 9.0×5 topics
  15. Space Suit2▲ 633×1 topic
  16. Heart Failure2▲ 11×4 topics
  17. Obesity2▲ 6.1×5 topics
  18. Pathogenesis2▲ 9.0×4 topics
  19. Vaccine2▲ 11×4 topics
  20. Cardiovascular Risk1▲ 12×3 topics
  21. Hybrid Rocket Propulsion1▲ 177×1 topic
  22. Regression Rate Behavior1▲ 177×1 topic
  23. Mars1▲ 100×1 topic
  24. Martian Surface1▲ 100×1 topic
  25. Chamber Quantification1▲ 40×1 topic
  26. Diastolic Function1▲ 40×1 topic
  27. Fibrosis1▲ 16×3 topics
  28. Solar System Abundances1▲ 66×1 topic
  29. Spacecraft Formation Flying1▲ 194×1 topic
  30. Terrestrial Planets1▲ 66×1 topic
  31. Trajectory Optimization1▲ 51×1 topic
  32. On-Orbit Servicing1▲ 123×1 topic
  33. Space Debris1▲ 123×1 topic

Which research topics does Acceleron Pharma (United States) publish most on?

By volume in 2022-now: Spacecraft Design and Technology, Space exploration and regulation, Pulmonary Hypertension Research and Treatments and Space Exploration and Technology.

Spacecraft Design and Technology: 3 fractional worksSpace exploration and regulation: 3 fractional worksPulmonary Hypertension Research and Treatments: 3 fractional worksSpace Exploration and Technology: 2 fractional worksRocket and propulsion systems research: 1 fractional worksPlanetary Science and Ex…1Planetary Science and Exploration: 1 fractional worksSpacecraft Dynamics and Control: 1 fractional worksCardiovascular Function and Risk Factors: 1 fractional worksAstro and Planetary Science: 1 fractional worksSpace Satellite Systems and Control: 1 fractional works
Aerospace EngineeringAstronomy and AstrophysicsPulmonary and Respiratory MedicineCardiology and Cardiovascular Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Spacecraft Design and Technology Aerospace Engineering 3 works
  2. 2 Space exploration and regulation Astronomy and Astrophysics 3 works
  3. 3 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 3 works
  4. 4 Space Exploration and Technology Aerospace Engineering 2 works
  5. 5 Rocket and propulsion systems research Aerospace Engineering 1 works
  6. 6 Planetary Science and Exploration Astronomy and Astrophysics 1 works
  7. 7 Spacecraft Dynamics and Control Aerospace Engineering 1 works
  8. 8 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 1 works
  9. 9 Astro and Planetary Science Astronomy and Astrophysics 1 works
  10. 10 Space Satellite Systems and Control Aerospace Engineering 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.5%not open69.5%

World: 40% of research is openly available.

with international co-authors19.0%domestic only81.0%

World: 18% is written across borders.

How has Acceleron Pharma (United States)'s research output changed?

Output in 2022-2025 was 5% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Acceleron Pharma (United States) as a percentage of every work published that year, 0.000096% in 2024.

still counting0.0010%0.0020%0.0030%Acceleron Pharma (United States)0.00027% in 202519801990200020102020

Fractional works of Acceleron Pharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Share Acceleron Pharma (United States)'s ranking

Acceleron Pharma (United States) on Science Explorer

A card with Acceleron Pharma (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Acceleron Pharma (United States). Posts are plain text and can be reported.